Announced Mon, 27 Apr · 20:06 IST
Mr. Mani Jain appointed as CFO & KMP effective 27 April 2026
Management Changes View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹37.50
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-4.4-6.1-6.7-6.5-3.2+1.3-1.9-2.7-14.9-16.2
Up moveDown movePending
AI summary
Kimia Biosciences Ltd has appointed Mr. Mani Jain as its Chief Financial Officer and Key Managerial Personnel, effective 27 April 2026. The announcement was filed with BSE. The available filing excerpt does not provide further details such as his prior experience, tenure, or the reason for the change in CFO role.
Likely market impact
A routine senior management appointment. New CFO may shape future financial strategy, capital allocation, and reporting. Monitor for continuity and execution.